Neuro-Ophthalmologic Symptoms Associated With the Moderna mRNA COVID-19 Vaccine: A Case Report
- PMID: 36185877
- PMCID: PMC9516661
- DOI: 10.7759/cureus.28523
Neuro-Ophthalmologic Symptoms Associated With the Moderna mRNA COVID-19 Vaccine: A Case Report
Abstract
Multiple neuro-ophthalmological symptoms, such as visual field defects, optic neuritis, and eye movement abnormalities, have been reported with coronavirus disease 2019 (COVID-19) infection. It is unknown whether the COVID-19 vaccine can result in similar neuro-ophthalmological symptoms post-vaccination. Here, we describe a case of optic neuritis after the administration of the mRNA COVID-19 Moderna vaccine. A 47-year-old female presented eight days after receiving the first dose of the Moderna COVID-19 vaccine with impaired vision in the left eye and symptoms consistent with optic neuritis. The patient underwent a workup for infectious etiology, autoimmune diseases, and allergies, which was negative. The patient was treated with a high dose of steroids resulting in the complete resolution of her symptoms. The patient was recommended against the second dose of the mRNA COVID-19 vaccine. Early detection and treatment of optic neuritis are important to prevent the long-term sequelae of neuritis with impaired vision.
Keywords: coronavirus; covid-19; moderna vaccine; mrna covid-19 vaccine; optic neuritis; sars-cov-2.
Copyright © 2022, Raxwal et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Hyperacute optic neuritis in a patient with COVID-19 infection and vaccination: a case report.BMC Ophthalmol. 2023 Feb 28;23(1):80. doi: 10.1186/s12886-023-02825-4. BMC Ophthalmol. 2023. PMID: 36855075 Free PMC article.
-
Optic Neuritis following Second Administration of COVID-19 Vaccine: A Case Report.Case Rep Ophthalmol. 2023 Aug 23;14(1):394-399. doi: 10.1159/000531526. eCollection 2023 Jan-Dec. Case Rep Ophthalmol. 2023. PMID: 37901633 Free PMC article.
-
Shot in the dark.Surv Ophthalmol. 2023 Jul-Aug;68(4):821-829. doi: 10.1016/j.survophthal.2022.09.003. Epub 2022 Sep 21. Surv Ophthalmol. 2023. PMID: 36150481 Free PMC article. Review.
-
Optic Neuritis After COVID-19 Vaccination: A Case Series and a Review of Literature.J Neuroophthalmol. 2024 Sep 1;44(3):330-336. doi: 10.1097/WNO.0000000000002161. Epub 2024 Jun 3. J Neuroophthalmol. 2024. PMID: 38829714 Review.
-
Bilateral Retinal Detachments in a Healthy 22-year-old Woman After Moderna SARS-COV-2 Vaccination.J Emerg Med. 2021 Dec;61(6):e146-e150. doi: 10.1016/j.jemermed.2021.07.034. Epub 2021 Jul 20. J Emerg Med. 2021. PMID: 34690021 Free PMC article.
Cited by
-
Systematic review exploring the clinical features of optic neuritis after SARS-CoV infection and vaccination.BMJ Open Ophthalmol. 2023 Dec 6;8(1):e001336. doi: 10.1136/bmjophth-2023-001336. BMJ Open Ophthalmol. 2023. PMID: 38057105 Free PMC article.
-
COVID-19 Vaccine-Associated Optic Neuropathy: A Systematic Review of 45 Patients.Vaccines (Basel). 2022 Oct 20;10(10):1758. doi: 10.3390/vaccines10101758. Vaccines (Basel). 2022. PMID: 36298623 Free PMC article. Review.
References
-
- World Health Organization (WHO). Coronavirus disease (COVID-19) [ Aug; 2022 ];https://www.who.int/health-topics/coronavirus#tab=tab_1 2022
-
- U.S. Food and Drug Administration. Silver Spring, MD: U.S. Food and Drug Administration; 2020. Moderna COVID-19 vaccine. FDA briefing document.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous